MADALIN 10mg Tablet 30s

Frequently asked questions

• Onset of action

  The amount of time required for this medicine to show its action is not clinically established.

• Duration of Effect

  The amount of time for which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Consumption of alcohol is not recommended while receiving this medicine since it may increase the risk of severe adverse effects. Contact your doctor if you experience symptoms like drowsiness, anxiety, depression, seizures, etc. Avoid performing activities that need high mental alertness like driving a vehicle or operating heavy machinery if alcohol and this medicine are used together.

• Is it habit forming?

  This medicine has a high potential for abuse which may lead to severe psychological or physical dependence.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the benefits and risks associated with the use of this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless necessary. Your doctor will determine the best course of treatment after evaluating the benefits and risks associated with the use of this medicine.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to MADALIN 10mg Tablet 30s or any other inactive ingredients present in the formulation.

• Agitation

  This medicine is not recommended for use in patients with marked anxiety, tension, and agitation due to the increased risk of worsening of the patient’s condition.

• Glaucoma

  This medicine is not recommended for use in patients with glaucoma due to the increased risk of worsening of the patient’s condition.

• Tourette's Syndrome

  This medicine is not recommended for use in patients with motor tics or in patients with a family history of diagnosis of Tourette's syndrome due to the increased risk of worsening of the patient’s condition.

• Monoamine oxidase inhibitors (MAO)

  This medicine is not recommended for use in patients undergoing treatment with monoamine oxidase inhibitors (MAOIs) such as selegiline, moclobemide etc. There should be a time gap of at least 14 days between stopping treatment with MAOIs and beginning treatment with this medicine to avoid their interaction.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the benefits and risks associated with the use of this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless necessary. Your doctor will determine the best course of treatment after evaluating the benefits and risks associated with the use of this medicine.

• Other medicines

  This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

• Use in the elderly

  This medicine is not recommended for use in patients aged above 65 since the risk of adverse events is significantly high.

• Use in children

  This medicine is not recommended for use in children below 6 years of age since the safety and efficacy of use are not clinically established.

• Heart diseases

  This medicine should be used with extreme caution in patients with active heart diseases or patients with a history of heart diseases since the risk of adverse effects or worsening of the patient's condition is significantly high. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Psychiatric disorders

  This medicine should be used with caution in patients with an active psychiatric disorder or patients with a history of psychiatric disorders, especially in children and adolescents. Use should be discontinued if new symptoms appear or old symptoms are worsened.

• Seizure disorders

  This medicine should be used with caution in patients with an active seizure disorder or patients with a history of seizure disorders since the risk of worsening of the patient's condition is significantly high. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Growth suppression

  Use of this medicine may slow growth in children. It is advised to regularly monitor your child's height and weight while this medicine is being taken. Use should be discontinued if the child is not gaining height or weight.

• Digestive tract disorders

  This medicine should be used with extreme caution in patients with obstructive disorders of the digestive tract. Use should be discontinued if symptoms worsen. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Abuse and dependence

  This medicine has a high potential for abuse and dependence and hence should be used with extreme caution in patients with a history of drug or substance abuse.

• Surgeries

  Report the use of this medicine to the doctor prior to surgery. Use of this medicine should be stopped a day before the planned surgery since it may interact with the anesthetics given, causing a sudden rise in the blood pressure levels.

• Driving or operating machinery

  Use of this medicine may cause blurred vision, dizziness, drowsiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Take this medicine exactly as prescribed by the doctor. Do not take in larger or smaller quantities than prescribed. Do not change the initial formulation prescribed without consulting your doctor. Report any adverse effects experienced to the doctor on priority. Do not stop the use of this medicine without consulting your doctor.

• medlineplus.gov - Methylphenidate [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a682188.html [cited 28/7/2020]. 2020